These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 36799423)
21. Design and synthesis of anti-cancer cyclopeptides containing triazole skeleton. Tahoori F; Balalaie S; Sheikhnejad R; Sadjadi M; Boloori P Amino Acids; 2014 Apr; 46(4):1033-46. PubMed ID: 24420338 [TBL] [Abstract][Full Text] [Related]
22. Re: Safety and Efficacy of 70-150 µm and 100-300 µm Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma. Tu J; Jia Z; Jiang G J Vasc Interv Radiol; 2015 Aug; 26(8):1251. PubMed ID: 26210251 [No Abstract] [Full Text] [Related]
23. Transarterial chemoembolization and sorafenib in hepatocellular carcinoma. Cabibbo G; Tremosini S; Galati G; Mazza G; Gadaleta-Caldarola G; Lombardi G; Antonucci M; Sacco R Expert Rev Anticancer Ther; 2014 Jul; 14(7):831-45. PubMed ID: 24850249 [TBL] [Abstract][Full Text] [Related]
24. [Progress in the study of some important natural bioactive cyclopeptides]. Xu WY; Zhao SM; Zeng GZ; He WJ; Xu HM; Tan NH Yao Xue Xue Bao; 2012 Mar; 47(3):271-9. PubMed ID: 22645749 [TBL] [Abstract][Full Text] [Related]
25. [Evidence and topics of chemotherapy for hepatocellular carcinoma]. Ueshima K; Kudo M Nihon Shokakibyo Gakkai Zasshi; 2017; 114(9):1621-1628. PubMed ID: 28883291 [No Abstract] [Full Text] [Related]
26. Imaging features following transarterial chemoembolization and radiofrequency ablation of hepatocellular carcinoma. Brennan IM; Ahmed M Semin Ultrasound CT MR; 2013 Aug; 34(4):336-51. PubMed ID: 23895906 [TBL] [Abstract][Full Text] [Related]
27. Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well taken. Samonakis DN; Notas G; Christodoulakis N; Kouroumalis EA Dig Dis Sci; 2008 Sep; 53(9):2359-65. PubMed ID: 18273705 [TBL] [Abstract][Full Text] [Related]
28. Practical management of hepatocellular carcinoma. Kuyvenhoven JPh ; Lamers CB; van Hoek B Scand J Gastroenterol Suppl; 2001; (234):82-7. PubMed ID: 11768566 [TBL] [Abstract][Full Text] [Related]
29. Combinative treatment of transarterial chemoembolization, celecoxib and lanreotide in unresectable hepatocellular carcinoma. Tong H; Li X; Wei B; Tang C Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):e65-6. PubMed ID: 25746137 [No Abstract] [Full Text] [Related]
30. Natural Cyclic Peptides as an Attractive Modality for Therapeutics: A Mini Review. Abdalla MA; McGaw LJ Molecules; 2018 Aug; 23(8):. PubMed ID: 30127265 [TBL] [Abstract][Full Text] [Related]
31. Successful treatment of an advanced hepatocellular carcinoma with the long-acting somatostatin analog lanreotide. Raderer M; Hejna MH; Kurtaran A; Kornek GV; Valencak JB; Oberhuber G; Vorbeck F; Virgolini I; Scheithauer W Am J Gastroenterol; 1999 Jan; 94(1):278-9. PubMed ID: 9934776 [TBL] [Abstract][Full Text] [Related]
32. DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center. Luz JH; Luz PM; Martin HS; Gouveia HR; Levigard RB; Nogueira FD; Rodrigues BC; de Miranda TN; Mamede MH Cancer Imaging; 2017 Feb; 17(1):5. PubMed ID: 28166821 [TBL] [Abstract][Full Text] [Related]
33. [Advances on cyclopeptides of plants]. Zhao M; Wang L; Feng ZM; Cai L; Jia QZ Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1172-1185. PubMed ID: 38621964 [TBL] [Abstract][Full Text] [Related]
36. Acute kidney injury after platinum-based transcatheter arterial chemoembolization and transarterial infusion chemotherapy in patients with hepatocellular carcinoma. Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Ohira H Jpn J Clin Oncol; 2020 Jan; 50(1):36-43. PubMed ID: 31665483 [TBL] [Abstract][Full Text] [Related]
37. Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy. Lencioni R Crit Rev Oncol Hematol; 2012 Aug; 83(2):216-24. PubMed ID: 22142656 [TBL] [Abstract][Full Text] [Related]
38. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma. Saviano A; Iezzi R; Giuliante F; Salvatore L; Mele C; Posa A; Ardito F; De Gaetano AM; Pompili M; J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848 [TBL] [Abstract][Full Text] [Related]
39. Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials. Huang Y; Zhang L; He M; Lai Z; Bu X; Wen D; Li Q; Xu L; Wei W; Zhang Y; Zhou Z; Chen M; Guo R; Shi M; Kan A Technol Cancer Res Treat; 2022; 21():15330338221117389. PubMed ID: 36529949 [No Abstract] [Full Text] [Related]
40. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma. Shin JU; Kim KM; Shin SW; Min SY; Park SU; Sinn DH; Gwak GY; Choi MS; Lee JH; Paik SW; Yoo BC; Koh KC Dig Liver Dis; 2014 Sep; 46(9):813-7. PubMed ID: 24881853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]